VENTRIP DIAGNOSTICS

VENTRIP DIAGNOSTICS Share · CA92281P2008 · A2ABKZ (XTSX) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of VENTRIP DIAGNOSTICS
No Price
Closing Price XTSX 01.05.2026: 0,17 CAD
01.05.2026 19:58
Current Prices from VENTRIP DIAGNOSTICS
ExchangeTickerCurrencyLast TradePriceDaily Change
XTSX: TSX-V
TSX-V
VPT.V
CAD
01.05.2026 19:58
0,17 CAD
0,03 CAD
+22,22 %
OTC: UTC
UTC
VPTDF
USD
01.05.2026 19:48
0,13 USD
0,03 USD
+30,91 %
Share Float & Liquidity
Free Float 88,35 %
Shares Float 165,79 M
Shares Outstanding 187,66 M
Company Profile for VENTRIP DIAGNOSTICS Share
Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is based in Toronto, Canada.

Company Data

Name VENTRIP DIAGNOSTICS
Company VentriPoint Diagnostics Ltd.
Website https://www.ventripoint.com
Primary Exchange XTSX TSX-V
WKN A2ABKZ
ISIN CA92281P2008
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Hugh MacNaught
Market Capitalization 24 Mio
Country Canada
Currency EUR
Employees -
Address 18 Hook Avenue, M6P 1T4 Toronto
IPO Date 2007-09-26

Stock Splits

Date Split
07.12.2015 1:10

Ticker Symbols

Name Symbol
Over The Counter VPTDF
Frankfurt 5V7.F
TSX-V VPT.V
More Shares
Investors who hold VENTRIP DIAGNOSTICS also have the following shares in their portfolio:
SIEMENS FINANC.16/46 REGS
SIEMENS FINANC.16/46 REGS Bond
SWEDBANK 25/30 MTN
SWEDBANK 25/30 MTN Bond